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Background: This study sought to investigate the association of the pre-procedural N/L ratio within-hospital and long-term outcomes among 
STEMI patients undergoing primary percutaneous coronary intervention (PCI).
methods: A total of 682 STEMI patients who were admitted within the first six hours ofsymptom onset were enrolled andstratified according to 
tertiles of N/L ratio based upon blood samples obtained in the emergency room upon admission.
results: The mean follow-up period was 43.3 months (1-131 months). In-hospital in-stent thrombosis, non-fatal myocardial infarction, and 
cardiovascular mortality increased as the N/L tertile ratio increased (p<0.001, p<0.001, p=0.003, respectively). Long-term in-stent thrombosis, 
non-fatal myocardial infarction and cardiovascular mortality also increased as the N/L ratio increased (p<0.001, p<0.001, p=0.002, respectively). 
Onmultivariate analysis, N/L ratio was an independent predictor of in-hospital major advanced cardiac events (MACE) (OR 1.189, 95% CI 1.000-
1.339; p<0.001) and an independent predictor of long-term MACE (OR 1.228, 95% CI 1.136-1.328; p<0.001).
conclusion: N/L ratio was an independent predictor of both in-hospital and long-term adverse outcomes amongSTEMI patients undergoing 
primary PCI. Our results suggest that the pre-procedural N/L ratio is an inexpensive and universally available parameter that can be used for STEMI 
risk stratification.
 
